P P Constantinides1. 1. SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406, USA.
Abstract
PURPOSE: This review highlights the state-of-the-art in pharmaceutical microemulsions with emphasis on self-emulsifying systems, from both a physical and biopharmaceutical perspective. Although these systems have several pharmaceutical applications, this review is primarily focused on their potential for oral drug delivery and intestinal absorption improvement. METHODS: Physicochemical characteristics and formulation design based on drug solubility and membrane permeability are discussed. RESULTS: Case studies in which lipid microemulsions have successfully been used to improve drug solubilization/dissolution and/or intestinal absorption of poorly absorbed drugs/peptides are presented. CONCLUSIONS: Drug development issues such as commercial viability, mechanisms involved, range of applicability, safety, scale-up and manufacture are outlined, and future research and development efforts to address these issues are discussed.
PURPOSE: This review highlights the state-of-the-art in pharmaceutical microemulsions with emphasis on self-emulsifying systems, from both a physical and biopharmaceutical perspective. Although these systems have several pharmaceutical applications, this review is primarily focused on their potential for oral drug delivery and intestinal absorption improvement. METHODS: Physicochemical characteristics and formulation design based on drug solubility and membrane permeability are discussed. RESULTS: Case studies in which lipid microemulsions have successfully been used to improve drug solubilization/dissolution and/or intestinal absorption of poorly absorbed drugs/peptides are presented. CONCLUSIONS: Drug development issues such as commercial viability, mechanisms involved, range of applicability, safety, scale-up and manufacture are outlined, and future research and development efforts to address these issues are discussed.
Authors: G Beskid; J Unowsky; C R Behl; J Siebelist; J L Tossounian; C M McGarry; N H Shah; R Cleeland Journal: Chemotherapy Date: 1988 Impact factor: 2.544
Authors: Jean F Cuiné; William N Charman; Colin W Pouton; Glenn A Edwards; Christopher J H Porter Journal: Pharm Res Date: 2007-02-15 Impact factor: 4.200